You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Psoralen plus ultraviolet A (PUVA) therapy can trigger autoimmune hemolytic anemia and lupus-like symptoms. Careful clinical and serological monitoring is crucial to manage potential iatrogenic risks associated with PUVA treatment.
Area of Science:
Background:
Observation:
Findings:
Implications: